Reactogenicity and immunogenicity of a Lyme disease vaccine in children 2-5 years old.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 11096024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Two doses of a recombinant Lyme disease vaccine (15 and 30 microg) were administered to children 2-5 years old (0-1-month schedule) and were well tolerated. Both doses were highly immunogenic with geometric mean titers 1 month after vaccination of 4366 and 9877 ELISA units (EU)/mL, respectively. Nearly all subjects had antibody levels of > or = 1400 EU/mL, suggesting protective tick titre for one tick season.
Medical subject headings
- Lipoproteins
- Lyme Disease
- Lyme Disease Vaccines